U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07621536) titled 'Diagnostic Accuracy of Eus Fnb in Difficult to Reach Lesions' on May 25.

Brief Summary: The present study aims at comprehensively assessing the diagnostic performance and safety profile of EUS-FNB as a primary diagnostic tool for suspected malignancies in anatomically complex or deeply situated regions, including the duodeno-jejunal, and hepatic hilar areas. By focusing on lesions that are challenging to reach due to their intricate anatomy or profound depth, investigators seek to provide valuable insights into the potential role of EUS-FNB in enhancing diagnostic accuracy and safety in these complex clinical scenarios.

Study Start ...